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Although the STN was targeted visually, we employed an atlas-based approach to explore the relationship between active contact locations and DBS outcomes. Based on fused MRI/CT-images, we identified Cartesian coordinates of active contacts with patient-specific Mai-atlas standardization. We computed linear mixed-effects models with x-/y-/z-coordinates as independent, hemispheres as within-subject, and test change scores as dependent variables. 
Results

Conclusions:
Our study provides evidence that more anterior, medial, and ventral STN-DBS is significantly related to more beneficial non-motor outcomes.
M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT
"Non-motor outcomes of STN-DBS in PD depend on active contact site" page 5/22
Introduction
Subthalamic nucleus (STN) deep brain stimulation (DBS) is an effective treatment option for patients with advanced Parkinson's disease (PD) improving quality of life (QoL) [1] , motor [2] , and non-motor symptoms (NMS) [3, 4] .
In PD, motor outcomes may depend on the location of active contacts, as previous studies have reported that neurostimulation in the zona incerta [5] or lateral STN border [6] may result in better motor outcome than stimulation of other STN subregions. However, other studies have challenged these observations and reported no significant differences of motor examination outcomes for different active contact sites within the STN and subthalamic region [7] [8] [9] [10] . Regarding NMS, previous studies have focused on neuropsychological [11, 12] and neuropsychiatric [7, 9] outcomes leading to the suggestion that focusing DBS to the dorsolateral STN may be beneficial for these outcomes [9, 12] . However, the relationship of active contact locations with non-neuropsychological, non-neuropsychiatric NMS and other important outcomes, such as QoL and activities of daily living (ADL), has not been systematically studied yet.
Therefore, we investigated a wide range of NMS and hypothesized that non-motor outcomes of STN-DBS in patients with PD depend on the location of active contacts. Furthermore, we explored the relationship with motor manifestations and QoL.
Materials and methods
Design and Ethical approval
We prospectively recruited patients in an international, multicenter, open-label study (DBS arm of the NILS study which also incorporated the EuroInf study; German Clinical Trials Register #6735) [3] and retrospectively analyzed imaging data from three centers changes, and excessive sweating) over the last four weeks [16] . The NMSS ranges from 0 (no NMS) to 360 (maximum NMS).
b) The patient-based NMSQuestionnaire (NMSQ) consisting of 30 dichotomized items was collected testing the presence of NMS over the last four weeks [17] . The NMSQ ranges from 0 (no NMS) to 30 (maximum NMS). c) Anxiety and depression were evaluated with subscales of the Hospital Anxiety and Depression Scale (HADS-A and -D) which respectively range from 0 (no anxiety/depression) to 21 (maximum anxiety/depression) [18] .
3) Motor aspects: Motor examination, ADL, and motor complications were assessed with corresponding parts of the Scales for Outcomes in Parkinson's disease (SCOPA-A, -B, and -C). The SCOPA score was derived from the Unified PD Rating Scale and the two scales strongly correlate [19] . SCOPA-A, -B, and -C range from 0 (no impairment) to 42, 21, and M A N U S C R I P T
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4) The therapeutic medical regimen was recorded calculating the LEDD according to the method of Tomlinson et al. [20] . The total electric energy delivered was computed according to the method of Koss et al. [21] .
Image analysis
Stereotactic preoperative MRI and postoperative CT images with spatial resolution of 1.00-1.25 mm were used for image analysis. Images were fused using the Optivise software (Medtronic Inc., Minneapolis/Minnesota/USA).
Locations of ventral and active contacts derived from these images were referenced to the mid-commissural point, the equidistant point on a line between the anterior and posterior commissure. To account for patients' individual anatomical differences, locations were standardized to the Mai-Atlas as suggested by Videen et al. [22] . This method standardizes midbrain nuclei to atlas space with a mean accuracy <1 mm. Further imaging methods employed in the present study are detailed elsewhere [23, 24] . These imaging methods were chosen as they can be easily accessed and reproduced by most DBS centers.
Statistical analysis
All statistical analyses were performed using SPSS (v24.0.0.0, SPSS Inc., Chicago/Illinois/USA). (Test baseline -Test follow-up ) were computed for additional explorative analyses. Effect sizes were calculated [25] . Furthermore, as we were interested in the relationship between NMS and LEDD changes, Spearman correlations between these outcome parameters were computed.
Exploratory linear mixed-effect models
Linear mixed-effect models (SPSS 'MIXED' command) were employed to explore a possible dependency of test change scores on active contact locations as this method is appropriate for data in which within-subject effects can be expected.
In the linear mixed-effects models, we entered active contacts' x-/y-/z-coordinates as independent and respective test change scores as dependent variables. To account for a possible dependency of clinical responses on x-/y-/z-coordinates from two hemispheres per patient, we included the binary parameter 'hemisphere' as a within-subject variable.
Subsequently, we tested two possible type III Maximum Likelihood models: In 'models A' the fixed effects included x-/y-/z-coordinates. In 'models B' we additionally included the threecomponent interaction (x*y*z-coordinates) to explore possible effects in three-dimensional space that could not be detected in 'models A'. Akaike's Information criterion was employed to compare the goodness of fit for 'models A and B'.
Dichotomization into "responders" and "non-responders"
Furthermore, according to a previously published method [3] , patients were classified as "responders", if they experienced a clinically relevant improvement using a designated cohortspecific threshold (>½ SD test baseline ), and remaining patients were classified as "nonresponders". To confirm results of linear mixed-effect models, we pooled bihemispheric active M A N U S C R I P T
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Results
We screened 88 consecutive patients from our database and included 65 patients with all necessary valid baseline and 6 months follow-up assessments in the analysis. Of these, 
Clinical outcomes at baseline and follow-up
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Cartesian coordinates of ventral and active contacts and stimulation characteristics
The mean bihemispheric total electric energy delivered was 159.9 µJoule (±206.8 
Exploratory linear mixed-effect models
Based on Akaike's information criterion, 'model A' was best suited to predict the majority of 
Dichotomization into "responders" and "non-responders"
Based on a cohort-specific method (>½ SD test baseline ), we defined the following thresholds for a clinically relevant improvement (/maximum score) for a classification into the "responder" Confirmatory analyses of neurostimulation locations of "responders" and "non-responders" resulted in the following significant differences:
• X-axis: No significant differences between neurostimulation locations of "responders"/"non-responders" were observed for the x-axis.
• Y-axis: In patients with clinically relevant improvements of NMSQ ("NMSQ responders"), mean active contact locations were 1.13 mm more anterior ("NMSQ responders": 0.12 mm ±1.75; "NMSQ non-responders": -1.25 mm ±1.72; p<0.001), and in "SCOPA-B responders" 1.10 mm more posterior compared to "SCOPA-B nonresponders" ("SCOPA-B responders": -1.12 mm ±1.76; "SCOPA-B non-responders": -0.02 mm ±1.84; p=0.005).
• Z-axis: In "NMSS responders", mean locations of neurostimulation were 0.69 mm more ventral than in "NMSS non-responders" ("NMSS responders": 
Discussion
In this prospective, observational, multicenter study including a cohort of 50 patients with PD, bilateral STN-DBS significantly improved QoL, non-motor and motor symptoms.
In line with previous studies, 
Non-motor outcomes and active contact locations
We were particularly interested in non-motor outcomes of DBS because of the emerging concept of non-motor effects of DBS [28] . Evidence of beneficial effects of STN-DBS on NMS was not only reported in studies employing clinician-administered and patient-based scales, e.g. for depression [29] , anxiety [30] , and pain [31] , but also in laboratory-assisted studies M A N U S C R I P T
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Several factors could explain the observed dependency of anxiety, depression, sleep, and gastrointestinal symptoms on active contact locations in our cohort:
• Anxiety and depression: Previous studies have reported an improvement of these neuropsychiatric symptoms by bilateral STN-DBS [36] and more beneficial outcome has been reported for more ventral active contact locations [37] . According to the concept of the functionally tripartite STN, the limbic subregion is located in the medial, anterior, and ventral STN and DBS closer to this STN subregion, as observed in our study, may impact upon neuropsychiatric symptoms. A possible mechanism of action is a modulation of the limbic circuitry which includes brain regions relevant to anxiety and depression (amygdala, nucleus accumbens, ventral striatum, mediodorsal thalamic nucleus, and the limbic and paralimbic cortices) [38] . Furthermore, a modulation of the medial forebrain bundle, located in close proximity of the medial STN (less than approximately 5 mm with even closer projections), could result in DBS effects on neuropsychiatric symptoms [39] . While neurostimulation of non-motor STN subregions or the medial forebrain bundle may result in beneficial effects on mood, early case reports have provided evidence for an induction of acute severe depression by substantia nigra stimulation [40, 41] .
• Sleep: Our analyses indicated that more ventral neurostimulation locations may be beneficial for sleep outcome. This may result from more spread of current to the pedunculopontine nucleus which is located ventral of the STN within approximately 5 mm with even closer projections [42] and has previously been associated with sleep improvement [43] .
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• Gastrointestinal symptoms: An improvement of gastric motility by bilateral STN-DBS has previously been reported [33] . Furthermore, studies have provided evidence that gastric motility is associated with an activation of autonomic centers, such as the frontal cortex, cingulate cortex, insula, ventral posterolateral and dorsomedial thalamic nuclei [44] which mainly project to and from non-motor STN subregions that are also located more anterior than the motor STN [38] .
Quality of life and motor outcomes and active contact locations
The fact that PDQ-8 SI improvement was significantly related to more anterior active contact locations may be explained by the fact that NMS scales performed similarly (significant relationship with anterior location of neurostimulation for HADS-D and NMSQ, trend for NMSS). The strong relationship between QoL and NMS is well established and, in fact, there is an overlap for depression items between scales (PDQ-8 item #3 "feeling depressed", HADSdepression subscale items, NMSQ item #16 "feeling sad").
Previous studies have provided evidence that motor STN subregions are located in the lateral/posterior/dorsal part [38] , which may explain that we observed more ADL improvement in posterior and more LEDD reduction in lateral neurostimulation locations. However, the relationship between motor manifestations and neurostimulation locations seems subtle as, in line with previous studies [7] [8] [9] [10] , responses for motor examination and complications were not significant. To include axial symptoms and account for ipsilateral corticospinal tract projections, we additionally carried out analyses with motor examination total score improvements. No significant relationship with neurostimulation locations was found for both scores.
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Methodological considerations and limitations
To account for a possible dependency of non-lateralized clinical outcomes, such as NMS, on bilateral active contact locations, we employed linear mixed-models with the within-subject variable 'hemisphere'.
In contrast, previous studies have focused on effects of unilateral DBS [9, 10, 45] or hemibody motor outcomes [6] , or have simplified statistical approaches by ignoring that clinical outcomes depend on bihemispheric DBS [11] and active contact locations are defined by threedimensional coordinates [6] . Furthermore, previous studies have dichotomized clinical outcomes [11, 37, 46, 47] and neurostimulation locations [8, 48, 49] . Therefore, we preferred the linear mixed-effect models approach as it integrates active contact locations and clinical outcomes as continuous data, i.e. without loss of information due to dichotomization.
Nevertheless, one limitation of our study is the simplified approach to account for the variance in patients' individual anatomy. The standardization to the Mai-atlas according to the method of Videen et al. corrects differences of patients' individual anatomy with an accuracy <1 mm [22] .
Considering the small differences of mean active contact locations in "responder"/"nonresponder" analyses, future studies are required to confirm the preliminary results of this study by employing more sophisticated imaging methods, such as diffusion-tensor imaging.
Furthermore, an approach based on active contact locations is limited by the fact that stimulation parameters were not considered although they are likely to influence clinical outcomes. Future studies will need to address these issues.
Although the cohort size of our study (n=50) is one of the biggest in studies of its kind, it did improvements may result in mood improvements and vice versa). Furthermore, one also has to acknowledge the importance of clinical practice as STN targeting and DBS programming were, as per clinical routine, guided by optimal motor effects while avoiding adverse effects.
Closely connected to this point, motor symptoms and LEDD reduction may be possible confounding factors which could influence NMS, although we have found no significant correlations between the change scores of these parameters. Furthermore, a confounding effect also seems unlikely because of the observation of opposing gradients of LEDD (bigger reduction in more lateral neurostimulation locations) and of non-motor and QoL outcomes (bigger improvement in more medial, anterior, and ventral location of active contacts) which suggests that the observations for LEDD and above mentioned clinical outcomes were not mediated by the same effect.
Due to these methodological limitations, the results of our study are preliminary and one cannot advise changes of clinical procedures on their basis. The advantage of the methods we have used, however, is that they are easily accessible and reproducible by most DBS centers.
As new technology, such as directional DBS, enables clinicians to focus neurostimulation on specific STN subregions [24, 50] , further studies are needed to investigate the clinical relevance of directing neurostimulation towards non-motor STN subregions.In this context, also a careful monitoring of clinical parameters, such as medication requirements, and possible behavioral adverse effects are key parameters to be taken into consideration when evaluating DBS targeting of STN subregions.
Conclusion
Our study supports the concept that DBS outcomes depend on active contact locations. The results presented here offer preliminary evidence that DBS in more anterior, medial, and ventral STN regions is beneficial for non-motor outcomes, such as anxiety, depression, sleep, Cartesian coordinates of geometric centers of contacts were identified based on fused preoperative MRI/postoperative CT images (Optivise software). Coordinates were referenced to the mid-commissural point and standardized to the Mai-Atlas. In cases with two or more active contacts the geometric center was calculated.
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